Carbapenem-resistant Klebsiella pneumoniae lineage CG307 displays urinary tract tropism

This study identifies the emerging carbapenem-resistant *Klebsiella pneumoniae* lineage CG307 as a distinct pathogen spreading across the Southern US that possesses unique genetic and phenotypic adaptations, including a novel capsule and high urease activity, which specifically drive its increased prevalence and virulence in urinary tract infections.

The Gist

Imagine the human body as a bustling city. Usually, the "police" (our immune system) and the "road signs" (antibiotics) keep the bad guys in check. But there's a notorious criminal gang called Carbapenem-resistant Klebsiella pneumoniae (CRKp). They are so tough that most standard police cars (antibiotics) can't stop them.

For a long time, the most famous branch of this gang, called CG258, was known as the "Pneumonia Boss." They liked to hang out in the lungs, causing severe respiratory infections.

However, a new, rising star in the criminal underworld has emerged: CG307. This paper is like a detective report revealing that CG307 isn't interested in the lungs; they have a special obsession with the urinary tract (the bladder and kidneys).

Here is the breakdown of what the scientists found, using some everyday analogies:

1. The Crime Spree is Spreading

The researchers looked at hospital records across the Gulf Coast (Texas, Alabama, Mississippi, Florida). They found that while the number of infections caused by the common "E. coli" gang stayed steady, the number of infections caused by this tough CRKp gang (specifically the CG307 branch) was skyrocketing. It's like noticing that while regular traffic jams are normal, a specific type of super-fast, indestructible truck is suddenly clogging up every highway in the region.

2. The "Specialized Toolkit"

Why is CG307 so good at attacking the bladder? The scientists looked at their genetic "toolkit" and found they have some unique gadgets that the old CG258 gang doesn't have:

• The High-Affinity Urea Transporter (UTS): Think of the bladder as a room filled with a specific fuel called "urea." Most bacteria struggle to eat this fuel. CG307, however, has a super-efficient vacuum cleaner (the UTS) that sucks up urea instantly and turns it into energy. This gives them a massive advantage in the bladder environment.
• The Extra Capsule: They have a second layer of protective armor (a capsule) that might help them hide from the body's defenses, though the study found this didn't necessarily make them "stickier" or more slimy than other strains.

3. The "Missing Fingerprint" Mystery

Usually, bacteria that infect the bladder use tiny, hair-like grappling hooks called Type 1 Fimbriae to grab onto the bladder wall and hold on tight. It's like a climber using a rope to scale a cliff.

• The Shock: The scientists discovered that about one-third of the CG307 criminals had actually lost the genes to build these grappling hooks.
• The Twist: Even without these hooks, these bacteria were still causing severe bladder infections! This is like finding a burglar who broke into a house without a crowbar or a lockpick. It suggests CG307 has a secret, unknown method of breaking in that we haven't figured out yet.

4. The "Super-Strong" Urease

The bacteria also have a super-charged engine called urease. When they break down urea, they release ammonia (which makes the urine basic).

• The Result: CG307 strains were found to have much higher urease activity than their rivals. This is like a factory that produces so much exhaust that it changes the chemistry of the room, potentially damaging the bladder walls and helping the bacteria build a fortress (biofilm) that is hard to clean out.

5. The "Mouse Test"

To see who was the toughest, the researchers put these bacteria into a mouse model (a controlled simulation of a human bladder infection).

• The Race: They compared the new CG307 gang against the old reference champion (a strain called TOP52).
• The Winner: The CG307 strain (named C234) didn't just win; it dominated. It grew faster in the "urine soup," had more powerful urease engines, and colonized the mouse bladder in much higher numbers than the old champion. It was like a Formula 1 car beating a standard sedan in a drag race.

The Bottom Line

This paper tells us that a new, highly resistant strain of bacteria (CG307) is taking over the urinary tract in the Southern US. They are better at eating bladder fuel, they have powerful chemical weapons (urease), and they can infect us even without the usual "grapple hooks" we thought were necessary.

Why should you care?
Because these bacteria are resistant to our best antibiotics, and they are spreading fast. We need to understand their secret weapons so doctors can catch them earlier and develop better treatments before they become an even bigger public health crisis.

Technical Summary

1. Problem Statement

Carbapenem-resistant Klebsiella pneumoniae (CRKp) is a top-priority pathogen identified by the WHO due to its high mortality, limited treatment options, and capacity to disseminate resistance. While the prototypical epidemic clade, CG258, is primarily associated with lower respiratory infections (pneumonia), there is a rising global burden of CRKp urinary tract infections (UTIs). Recent data suggests the emergent CG307 lineage is increasingly linked to UTIs, particularly in the Southern United States. However, the mechanisms driving this specific "urinary tract tropism" remain poorly understood. Key questions include:

• Is the prevalence of CRKp UTIs increasing relative to other pathogens (e.g., E. coli) in the Gulf Coast region?
• Does CG307 possess specific phenotypic adaptations (e.g., growth in urine, virulence factors) that allow it to outcompete other lineages in the urinary tract?
• How does CG307 colonize the urinary tract given that a significant portion of isolates lack the canonical type-1 fimbriae (fim operon), a major virulence factor for UTIs?

2. Methodology

The study employed a multi-faceted approach combining epidemiological surveillance, genomic analysis, and phenotypic characterization:

• Epidemiological Surveillance:
  • Analyzed clinical data from two large health systems: HealthConnect Texas (Greater Houston, 2020–2024) and USA Health (Southern Alabama/Mississippi/Florida, 2017–2024).
  • Calculated the incidence of K. pneumoniae UTIs relative to Uropathogenic E. coli (UPEC) to determine trends.
• Genomic Characterization:
  • Selected 13 representative CG307 isolates (collected 2017–2024) covering various anatomical sites (urinary vs. respiratory) and clinical statuses.
  • Performed Whole Genome Sequencing (Illumina/Oxford Nanopore) and phylogenetic analysis (SNP-based) to assess relatedness.
  • Screened for specific accessory genes: UTS (high-affinity urea transporter), cp2 (second capsule cluster), glgBXCAP (glycogen synthesis), and the fim operon.
• Phenotypic Assays:
  • Growth Curves: Compared growth in nutrient-rich LB broth vs. nutrient-limited Artificial Urine (AU) media against reference strains (CG307, CG258, TOP52, UTI89).
  • Mucoviscosity: Assessed capsule production using the "string test" and quantitative OD600 supernatant ratios to determine if the cp2 locus alters hypermucoviscosity.
  • Urease Activity: Measured urease activity over time in urea-containing broth to assess nitrogen acquisition capabilities.
  • In Vivo Mouse Model: Used a murine UTI model (C57BL/6 female mice) to compare bladder and kidney colonization of a representative CG307 strain (C234) against reference strains (UTI89, TOP52, and a TOP52Δfim mutant).

3. Key Contributions

• Epidemiological Expansion: Confirmed that the CG307 lineage is not limited to Houston but is spreading across the broader Gulf Coast region (Alabama, Mississippi, Florida).
• Genomic Paradox: Identified that ~38% of CG307 urinary isolates possess a ~30 kb chromosomal deletion removing the fim operon (type-1 fimbriae), yet these strains still cause symptomatic UTIs, suggesting alternative colonization mechanisms.
• Phenotypic Adaptation: Demonstrated that CG307 strains possess distinct fitness advantages in the urinary tract environment compared to the reference UTI strain TOP52 and the respiratory-associated CG258.
• Mechanistic Insight: Linked the presence of the UTS (urea transporter) and urease activity to enhanced survival in the nitrogen-limited urinary tract, independent of the fim operon.

4. Key Results

• Increasing Prevalence: The proportion of K. pneumoniae UTIs relative to UPEC increased significantly in both Houston and the broader Gulf Coast between 2017 and 2024, while UPEC rates remained stable.
• Genomic Findings:
  • All 13 CG307 isolates carried the UTS (UrtABC/AmiF) and cp2 gene clusters.
  • 5/13 isolates lacked the fim operon due to a large deletion but were isolated from urinary tract infections (symptomatic or asymptomatic).
• Growth in Artificial Urine:
  • CG307 strains exhibited significantly higher growth in artificial urine compared to the reference strain TOP52.
  • Growth was comparable to the highly virulent UPEC strain UTI89, indicating robust adaptation to the urinary nutrient environment.
• Mucoviscosity:
  • Contrary to the hypothesis that cp2 would induce hypermucoviscosity, mucoviscosity levels in CG307 were similar to or lower than TOP52. The cp2 locus does not appear to drive a hypermucoviscous phenotype in this lineage.
• Urease Activity:
  • CG307 strains displayed significantly higher urease activity compared to CG258 and TOP52.
  • High urease activity was observed regardless of the isolation site (urinary vs. respiratory), suggesting a constitutive trait of the lineage.
• In Vivo Virulence:
  • In the mouse model, the CG307 strain C234 colonized the bladder at levels significantly higher than TOP52 and comparable to UTI89.
  • This occurred despite C234 lacking the fim operon (in some isolates) or possessing it, proving that CG307 utilizes non-canonical mechanisms for bladder colonization.

5. Significance

• Public Health Threat: The study highlights a shifting epidemiological landscape where a multidrug-resistant (MDR) lineage (CG307) is rapidly displacing or co-circulating with other pathogens in the urinary tract, a common site for hospital-acquired infections.
• Novel Pathogenesis: The discovery that CG307 can cause UTIs without the canonical fim operon challenges current dogmas regarding uropathogen virulence. It suggests the existence of alternative adhesins (potentially the $\pi$-pili or type 3 fimbriae) or metabolic adaptations that drive colonization.
• Therapeutic Implications: The high urease activity and efficient urea uptake (via UTS) suggest that targeting urea metabolism or urease could be a viable therapeutic strategy for CRKp UTIs.
• Surveillance Needs: The findings underscore the urgent need for active surveillance of CG307 across the Southern US and globally, as its specific adaptations make it a formidable pathogen in the urinary tract, potentially leading to increased morbidity and mortality due to limited treatment options.

In conclusion, the CG307 lineage has evolved specific genetic and phenotypic traits—particularly enhanced urea metabolism and robust growth in urine—that facilitate its dominance in the urinary tract, independent of traditional virulence factors like type-1 fimbriae.